Synthesis and characterization of luminescent cerium oxide nanoparticles

Nanomedicine

Volumn 5, Issue 2, 2010, Pages 233-242

  Woan, Karran ^a   Tsai, Yi Yang ^a   Sigmund, Wolfgang ^a,b  

^a University of Florida   (United States)

^b Hanyang University   (South Korea)

Author keywords

Catalysts catalysis; Cerium; Cerium compounds; Colloids; Erbium; Erbium compounds; Luminescence

Indexed keywords

CERIUM OXIDE; ERBIUM; HYDROGEN PEROXIDE; NANOPARTICLE; CERIC OXIDE; CERIUM; METAL NANOPARTICLE; SURFACTANT;

AQUEOUS SOLUTION; ARTICLE; CATALYSIS; CHEMICAL COMPOSITION; CONCENTRATION (PARAMETERS); CONFOCAL MICROSCOPY; CONTROLLED STUDY; LUMINESCENCE; NANOFABRICATION; PARTICLE SIZE; PRIORITY JOURNAL; REVERSE MICELLE; ULTRAVIOLET RADIATION; CHEMISTRY; HUMAN; METHODOLOGY; NANOMEDICINE; NANOTECHNOLOGY; THERMOGRAVIMETRY;

CATALYSIS; CERIUM; ERBIUM; HUMANS; HYDROGEN PEROXIDE; LUMINESCENCE; METAL NANOPARTICLES; MICROSCOPY, CONFOCAL; NANOMEDICINE; NANOPARTICLES; NANOTECHNOLOGY; PARTICLE SIZE; SURFACE-ACTIVE AGENTS; THERMOGRAVIMETRY; ULTRAVIOLET RAYS;

EID: 77952579867     PISSN: 17435889     EISSN: None     Source Type: Journal    
DOI: 10.2217/nnm.09.106     Document Type: Article

References (41)

1. Tsai YY, Oca-Cossio J, Agering K et al.: Novel synthesis of cerium oxide nanoparticles for free radical scavenging. Nanomedicine 2(3), 325-332 (2007).
2. 2 solid solution nanoparticles. Nanomedicine 3(5), 637-645 (2008).
3. Tarnuzzer RW, Colon J, Patil S, Seal S: Vacancy engineered ceria nanostructures for protection from radiation-induced cellular damage. Nano. Lett. 5(12), 2573-2577 (2005).
4. Chen J, Patil S, Seal S, McGinnis JF: Nanoceria particles prevent ROI-induced blindness. Adv. Exp. Med. Biol. 613, 53-59 (2008).
5. Chen J, Seal S, Sezate SA et al.: Nanoceria particles confer neuroprotection in retinal cells in vitro. Invest. Ophthalmol. Vis. Sci. 46 (2005) (Abstract 186).
6. Chen JP, Patil S, Seal S, McGinnis JF: Rare earth nanoparticles prevent retinal degeneration induced by intracellular peroxides. Nat. Nanotechnol. 1(2), 142-150 (2006).
7. Niu JL, Azfer A, Rogers LM, Wang XH, Kolattukudy PE: Cardioprotective effects of cerium oxide nanoparticles in a transgenic murine model of cardiomyopathy. Cardiovasc. Res. 73(3), 549-559 (2007).
8. Das M, Patil S, Bhargava N et al.: Auto-catalytic ceria nanoparticles offer neuroprotection to adult rat spinal cord neurons. Biomaterials 28(10), 1918-1925 (2007).
9. Rzigalinski BA, Meehan K, Davis RM, Xu Y, Miles WC, Cohen CA: Radical nanomedicine. Nanomedicine 1(4), 399-412 (2006).
10. Singh N, Cohen CA, Rzigalinski BA: Treatment of neurodegenerative disorders with radical nanomedicine. Ann. NY Acad. Sci. 1122, 219-230 (2007).
11. Babu S, Thanneeru R, Inerbaev T et al.: Dopant-mediated oxygen vacancy tuning in ceria nanoparticles. Nanotechnology 20(8), 85713 (2009).
12. Sugiura M, Ozawa M, Suda A, Suzuki T, Kanazawa T: Development of innovative three-way catalysts containing ceria-zirconia solid solutions with high oxygen storage/release capacity. Bull. Chem. Soc. Jpn. 78(5), 752-767 (2005).
13. Patil S, Sandberg A, Heckert E, Self W, Seal S: Protein adsorption and cellular uptake of cerium oxide nanoparticles as a function of z potential. Biomaterials 28(31), 4600-4607 (2007).
14. Patil S, Reshetnikov S, Haldar MK, Seal S, Mallik S: Surface-derivatized nanoceria with human carbonic anhydrase II inhibitors and fuorophores: a potential drug delivery device. J. Phys. Chem. C Nanomater. Interfaces 111(24), 8437-8442 (2007).
15. 3+ powders produced by 785 nm laser. J. Solid State Chem. 180(1), 127-131 (2007).
16. 3 using pyrolitic precursors. Br. Ceram. Trans. 100, 155-158 (2001).
17. Limbach LK, Li YC, Grass RN et al.: Oxide nanoparticle uptake in human lung fbroblasts: Effects of particle size, agglomeration, and diffusion at low concentrations. Environ. Sci. Technol. 39(23), 9370-9376 (2005).
18. Brunner TJ, Wick P, Manser P et al.: In vitro cytotoxicity of oxide nanoparticles: Comparison to asbestos, silica, and the effect of particle solubility. Environ. Sci. Technol. 40(14), 4374-4381 (2006).
19. Lin WS, Huang YW, Zhou XD, Ma YF: Toxicity of cerium oxide nanoparticles in human lung cancer cells. Int. J. Toxicol. 25(6), 451-457 (2006).
20. Park EJ, Choi J, Park YK, Park K: Oxidative stress induced by cerium oxide nanoparticles in cultured BEAS-2B cells. Toxicology 245(1-2), 90-100 (2008).
21. Lanone S, Rogerieux F, Geys J et al.: Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines. Part Fibre Toxicol. 6, 14 (2009).
22. Changez M, Varshney M: Aerosol-OT microemulsions as transdermal carriers of tetracaine hydrochloride. Drug Dev. Ind. Pharm. 26(5), 507-512 (2000).
23. Junyaprasert VB, Boonme P, Wurster DE, Rades T: Aerosol OT microemulsions as carriers for transdermal delivery of hydrophobic and hydrophilic local anesthetics. Drug Deliv. 15(5), 323-330 (2008).
24. Constantinidis I, Oca-Cossio J, Tsai YY, Simpson NE, Atkinson M, Sigmund W: Novel cerium oxide nanoparticies for free radical scavenging. Diabetes 56, A415-A415 (2007).
25. Hirano M, Kato E: Hydrothermal synthesis of nanocrystalline cerium(IV) oxide powders. J. Am. Ceram. Soc. 82(3), 786-788 (1999).
26. Masui T, Hirai H, Imanaka N, Adachi G, Sakata T, Mori H: Synthesis of cerium oxide nanoparticles by hydrothermal crystallization with citric acid. J. Mater. Sci. Lett. 21(6), 489-491 (2002).
27. Zhang J, Ohara S, Umetsu M, Naka T, Hatakeyama Y, Adschiri T: Colloidal ceria nanocrystals: a tailor-made crystal morphology in supercritical water. Adv. Mater. Weinheim 19(2), 203-206 (2007).
28. Kaneko K, Inoke K, Freitag B et al.: Structural and morphological characterization of cerium oxide nanocrystals prepared by hydrothermal synthesis. Nano. Lett. 7(2), 421-425 (2007).
29. Heckert EG, Karakoti AS, Seal S, Self WT: The role of cerium redox state in the SOD mimetic activity of nanoceria. Biomaterials 29(18), 2705-2709 (2008).
30. Korsvik C, Patil S, Seal S, Self WT: Superoxide dismutase mimetic properties exhibited by vacancy engineered ceria nanoparticles. Chem. Commun. (10), 1056-1058 (2007).
31. Schafer H, Ptacek P, Kompe K, Haase M: Lanthanide-doped NaYF4 nanocrystals in aqueous solution displaying strong up-conversion emission. Chem. Mater. 19(6), 1396-1400 (2007).
32. Hampl J, Hall M, Mufti NA et al.: Upconverting phosphor reporters in immunochromatographic assays. Anal. Biochem. 288(2), 176-187 (2001).
33. Qian L, Bera D, Tseng T-K, Holloway PH: High effciency photoluminescence from silica-coated CdSe quantum dots. Appl. Phys. Lett. 94(7), 073112-073113 (2009).
34. Kramer KW, Biner D, Frei G, Gudel HU, Hehlen MP, Luthi SR: Hexagonal sodium yttrium fuoride based green and blue emitting upconversion phosphors. Chem. Mater.16(7), 1244-1251 (2004).
35. Abdul Jalil R, Zhang Y: Biocompatibility of silica coated NaYF4 upconversion fuorescent nanocrystals. Biomaterials 29(30), 4122-4128 (2008).
36. Devaraju MK, Yin S, Sato T: Morphology control of cerium oxide particles synthesized via a supercritical solvothermal method. ACS Appl. Mater. Interfaces 1(11), 2694-2698 (2009).
37. Sathyamurthy S, Leonard KJ, Dabestani RT, Paranthaman MP: Reverse micellar synthesis of cerium oxide nanoparticies. Nanotechnology 16(9), 1960-1964 (2005).
38. 2) nanostructures independent of oxygen vacancies. J. Phys. Condens. Matter 20(16) (2008).
39. Notingher I, Verrier S, Romanska H, Bishop AE, Polak JM, Hench LL: In situ characterisation of living cells by Raman spectroscopy. Spectroscopy 16(2), 43-51 (2002).
40. Pyrgiotakis G, Bhowmick TK, Finton K et al.: Cell (A549)-particle (Jasada Bhasma) interactions using Raman spectroscopy. Biopolymers 89(6), 555-564 (2008).
41. Hilderbrand SA, Shao F, Salthouse C, Mahmood U, Weissleder R: Upconverting luminescent nanomaterials: application to in vivo bioimaging. Chem. Commun. (28), 4188-4190 (2009).